Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
euticals Inc - Westchester, New York-based pharmaceutical company - Says it expects second quarter 2024 earnings calcu ...
The EU has approved Sanofi's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (CO ...
Sanofi SA and Regeneron Pharmaceuticals Inc on Thursday said the US Food & Drug Administration approved Dupixent as t ...
A number of leading pharmaceutical companies on Monday reported positive trial results on the treatment of lymphoma, ...
A Regeneron Pharmaceuticals Inc and Sanofi Inc new drug therapy to treat moderate to severe eczema in young children ...
Regeneron Pharmaceuticals Inc soared on Thursday after saying two trials investigating aflibercept given at a higher ...
Sanofi SA on Thursday said it has agreed to assign worldwide exclusive rights to cancer drug Libtayo to partner Regen ...
Regeneron Pharmaceuticals Inc, a New York-based biotechnology firm, and Paris-based Sanofi SA announced on Tuesday th ...
-based healthcare company - and Regeneron Pharmaceuticals Inc - New York-based biotechnology company - Say detailed po ...
Sanofi SA and Regeneron Pharmaceuticals Inc said on Saturday that in a phase 3 trial of its monoclonal antibody Dupix ...
Sanofi SA and Regeneron Pharmaceuticals Inc said on Friday that a phase three trial evaluating dupilumab in patients ...
Sanofi SA and Regeneron Pharmaceuticals Inc on Wednesday said the second phase-three trial in Dupixent, evaluating it ...
Roche Holding AG and Regeneron Pharmaceuticals Inc's co-developed antibody cocktail was on Friday approved by the Eur ...
Sanofi SA and Regeneron Pharmaceuticals Inc said Monday the second phase 3 trial in Dupixent, evaluating its effectiv ...
Tarrytown, New York-based Regeneron Pharmaceuticals Inc said Thursday that its biologics license application to the U ...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관